Inhaled Triple Therapy Reduces COPD Exacerbations Inhaled Triple Therapy Reduces COPD Exacerbations

Inhaled triple therapy, consisting of inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta2-agonist, reduces exacerbations in patients with severe chronic obstructive pulmonary disease (COPD), compared with dual bronchodilator therapy, according to results from the TRIBUTE trial.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news